Full text not available from this repository.

Abstract

Despite changes in antiarrhythmic drug (AAD) choice in patients with atrial fibrillation (AF), trends in AAD prescribing remain not investigated. We aimed to examine these changes using a nationwide Australian general practice data from 2009 to 2018. Over the 10 years, AAD prescribing in patients with AF decreased, which was mainly due to a reduction in the use of amiodarone, sotalol and digoxin. In contrast, the use of beta-blockers and flecainide increased.

Item Type:	Article
Authors/Creators:	Bezabhe, WM and Bereznicki, LR and Radford, J and Salahudeen, MS and Garrahy, E and Wimmer, BC and Bindoff, I and Peterson, GM
Keywords:	antiarrhythmic drugs, atrial fibrillation, primary care, arrhythmia
Journal or Publication Title:	Internal Medicine Journal
Publisher:	Blackwell Publishing Asia
ISSN:	1444-0903
DOI / ID Number:	10.1111/imj.15514
Copyright Information:	© 2021 Royal Australasian College of Physicians
Related URLs:	Google Scholar: Bezabhe, WM Google Scholar: Bereznicki, LR UTAS Profile: Bereznicki, LR Google Scholar: Radford, J UTAS Profile: Radford, J Google Scholar: Salahudeen, MS UTAS Profile: Wimmer, BC Google Scholar: Bindoff, I UTAS Profile: Bindoff, I UTAS Profile: Peterson, GM
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page